Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

NeutriSci International Inc V.NU.H

Alternate Symbol(s):  NRXCF

NeutriSci International Inc. (NeutriSci) is a Canada-based company, which specializes in the production, and formulation of nutraceutical products within the business-to-business (B2B) industry. The Company is focused on the market development for its nutraceutical products. Its products utilize patented form of Pterostilbene called pTeroPure. pTeroPure Pterostilbene is a form of all-trans Pterostilbene that is found naturally in blueberries and is manufactured for NeutriSci by ChromaDex Corp. (ChromaDex) in the United States. NeutriSci’s neuenergy product is an energy tab designed to deliver enhanced focus and mental clarity with no sugar, no calories and no crash that is associated with energy products. It has developed proprietary IP and technology (NeutriSci IP) that creates an efficient method of bilingual absorption of nutraceuticals into the bloodstream. NeutriSci’s IP can be applied to many different categories in the beverage, food, and nutraceutical space.


TSXV:NU.H - Post by User

Bullboard Posts
Post by qwayludeon Mar 15, 2019 8:13pm
99 Views
Post# 29494466

sedar

sedar
https://www.sedar.com/GetFile.do?lang=EN&docClass=8&issuerNo=00015938&issuerType=03&projectNo=02886336&docId=4479350

NEUTRISCI CLOSES FIRST TRANCHE OF FINANCINGVancouver, British ColumbiaMarch 15, 2019 - NeutriSci International Inc. (“NeutriSci” or the “Company”)(TSX-V: NU, OTCQB: NRXCF, FRANKFURT: 1N9) the innovator and pioneer behind neuenergy® is pleased to announce that it has completed the first tranche of a non-brokered private placement (the “Placement”) in which it raised gross proceeds of $170,000.This tranche of the Placement consisted of 2,125,000 units (the “Units”) of the Company at a price of $0.08 per Unit. Each Unit consists of one common share and one-half of one common share purchase warrant, with each full warrant entitling the holder to acquire an additional common share of the Company at a price of $0.12 until March 15, 2020. All securities issued in connection with the Placement are subject to a hold period expiring July 16, 2019. The Company intends to close a final tranche of the Placement for up to an additional $330,000 via the issuance of up to 4,125,000 Units. Proceeds of the Placement will be used for marketing programs, production runs, and for general corporate purposes.On Behalf of the Board of Directors ofNEUTRISCI INTERNATIONAL INC. Investor RelationsNeutriSci International Inc. Tel: (403) 264-6320Email: info@neutrisci.com
Bullboard Posts